Back

The Oncogenic Role of Human Microcephalin Gene Revealed by Pan-Cancer Analyses

Wang, z.; Li, M.; Liu, Z.; Kang, W.; Cui, Y.; Han, J.; Du, W.

2022-11-20 oncology
10.1101/2022.11.18.22282275
Show abstract

The human gene microcephalin (MCPH1) plays a key role in DNA damage-induced cellular responses and chromosome condensation. Recent clinical studies proposed MCPH1 as a tumor suppressor gene in lung cancer, pancreatic cancer, and breast cancer, yet its roles remain poorly understood in other types of tumors. Pan-cancer analyses of MCPH1 are urgently required to help us understand the potential molecular functions of MCPH1 in other types of tumors. Here, we used several bioinformatic database and tools, including TCGA, GEO, ONCOMINE, and Human Protein Atlas to investigate the role of MCPH1 in 33 tumor types. We found that the expression of MCPH1 in tumor cases and normal cases were significantly different, and the higher expression of MCPH1 generally predicted poor overall survival for tumor patients, such as acute myeloid leukemia, liver hepatocellular carcinoma, and pancreatic adenocarcinoma. Meanwhile, lower expression of the MCPH1 gene was related to poor OS prognosis for KIRC and gastric cancer. Moreover, the expression level of MCPH1 was highly associated with the immune microenvironment. Our result provides some fresh light into the oncogenic roles of MCPH1 in various human cancers and revealed that MCPH1 may be a potential diagnostic and prognostic marker in LAML, PAAD, and gastric cancer.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Cancers
based on 57 papers
Top 2%
11.0%
2
Scientific Reports
based on 701 papers
Top 13%
11.0%
3
Frontiers in Oncology
based on 34 papers
Top 1%
7.5%
4
Aging
based on 18 papers
Top 0.2%
5.7%
5
PLOS ONE
based on 1737 papers
Top 67%
5.2%
6
Clinical and Translational Medicine
based on 11 papers
Top 0.1%
4.4%
7
Genomics, Proteomics & Bioinformatics
based on 10 papers
Top 0.3%
4.4%
8
Nature Communications
based on 483 papers
Top 23%
2.8%
50% of probability mass above
9
Frontiers in Genetics
based on 32 papers
Top 1%
2.5%
10
PeerJ
based on 46 papers
Top 3%
2.3%
11
Cancer Medicine
based on 17 papers
Top 2%
2.2%
12
Cancer Epidemiology, Biomarkers & Prevention
based on 14 papers
Top 2%
1.8%
13
British Journal of Cancer
based on 22 papers
Top 2%
1.7%
14
Communications Biology
based on 36 papers
Top 1%
1.7%
15
eLife
based on 262 papers
Top 18%
1.6%
16
Frontiers in Pharmacology
based on 27 papers
Top 3%
1.3%
17
Clinical Cancer Research
based on 22 papers
Top 3%
1.3%
18
International Journal of Radiation Oncology*Biology*Physics
based on 13 papers
Top 2%
1.3%
19
iScience
based on 74 papers
Top 5%
1.3%
20
International Journal of Molecular Sciences
based on 39 papers
Top 2%
1.3%
21
npj Precision Oncology
based on 14 papers
Top 3%
1.2%
22
Frontiers in Neuroscience
based on 29 papers
Top 3%
1.2%
23
JCO Precision Oncology
based on 11 papers
Top 2%
1.2%
24
Heliyon
based on 57 papers
Top 9%
1.2%
25
EMBO Molecular Medicine
based on 15 papers
Top 2%
1.2%
26
Briefings in Bioinformatics
based on 11 papers
Top 0.6%
0.8%
27
PLOS Genetics
based on 39 papers
Top 5%
0.8%
28
BMC Cancer
based on 21 papers
Top 5%
0.8%
29
Medicine
based on 29 papers
Top 8%
0.8%
30
Neuro-Oncology Advances
based on 14 papers
Top 3%
0.7%